For Drug Discovery Online, I'm seeking expertise from individual scientists, SMEs, academic researchers, consultants, and executives at biotech/biopharma companies. Topic options are up to the author and their area of expertise. Some examples are new approach methodologies (NAMs), antibody-drug conjugates (ADCs), oligonucleotides (oligos), women's health in therapeutics, infectious diseases research, or the overall regulatory landscape. Our audience is comprised of professionals working in drug discovery and preclinical drug development. When responding, what are you hoping our audience will gain from this information? Here are some questions for consideration to help you get started: 1. What are the best practices or tips for implementation of your topic? 2. What are key pitfalls to avoid and what are your recommendations for overcoming them? 3. What regulatory compliance tips might you have? 4. What are emerging trends you are seeing in the space? Other intel welcome. *** We do not publish vendors or suppliers (companies that sell products or services, CROs, CDMOs). Additionally, we cannot publish content that is directly or indirectly promotional. At this time, we are unable to accept AI-generated images. Here are our writing guidelines: https://www.drugdiscoveryonline.com/doc/guest-expert-article-guidelines-0001 Drug Discovery Online is a specialized B2B digital media outlet by Life Science Connect for professionals working in drug discovery and preclinical drug development.